National Heart, Lung, and Blood Institute; Amended Notice of Meeting, 19214 [2016-07502]
Download as PDF
19214
Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices
requirements of 35 U.S.C. 209 and 37
CFR part 404.
Complete applications for a license in
the field of use filed in response to this
notice will be treated as objections to
the grant of the contemplated start-up
exclusive license. Comments and
objections submitted to this notice will
not be made available for public
inspection and, to the extent permitted
by law, will not be released under the
Freedom of Information Act, 5 U.S.C.
552.
Dated: March 24, 2016.
Susan Ano,
Technology Development Coordinator,
NINDS Technology Transfer, National
Institutes of Health.
[FR Doc. 2016–07496 Filed 4–1–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Notice is hereby given to clarify the
meeting times of the Sleep Disorders
Research Advisory Board, April 14–15,
2016, NHLBI/National Institutes of
Health, Two Rockledge Center, 6701
Rockledge Drive, Conference Room
9100/9104, Bethesda, MD, which was
published in the Federal Register on
March 14, 2016, 81 FR 13399.
Time: April 14 1:00 p.m. to 5:00 p.m.,
April 15 8:30 a.m. to 3:00 p.m.
Agenda: Information will be
presented on the status of selected NIH
sleep research programs and interagency coordination activities. The
Sleep Disorders Research Advisory
Board will discuss a potential
framework for a revision of the NIH
Sleep Disorders Research Plan. The
Board will also hear brief presentations
from organizations and individuals
interested in NIH sleep research
programs and planning.
Dated: March 29, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–07502 Filed 4–1–16; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:03 Apr 01, 2016
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Integrative
Perspectives in Early Life.
Date: May 4, 2016.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 2C212, 7201 Wisconsin
Avenue, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Carmen Moten, MPH,
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20892, 301–402–7703
cmoten@mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Nutrient
Signaling and Bone Loss.
Date: May 4, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ramesh Vemuri, Ph.D.,
Chief, Scientific Review Branch, Scientific
Review Branch, National Institue On Aging,
National Institites Of Health, 7201 Wisconsin
Avenue, Suite 2C–212, Bethesda, MD 20892,
301–402–7700, rv23r@nih.gov
Name of Committee: National Institute on
Aging Special Emphasis Panel; Alzheimer’s
Disease Drug Development.
Date: May 17, 2016.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging, The
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, National
Institute On Aging, Gateway Building 2C/
212, 7201 Wisconsin Avenue, BETHESDA,
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
MD 20892 301–496–9666
parsadanian@commat;nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Integrative
Approach to Delirium and Dementia.
Date: May 18, 2016.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Aging,
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Isis S. Mikhail, National
Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C12, Bethesda,
MD 20892301–402–7704 mikhaili@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: March 29, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–07547 Filed 4–1–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of HHS-Certified
Laboratories and Instrumented Initial
Testing Facilities Which Meet Minimum
Standards To Engage in Urine Drug
Testing for Federal Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) notifies federal
agencies of the laboratories and
Instrumented Initial Testing Facilities
(IITF) currently certified to meet the
standards of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908);
September 30, 1997 (62 FR 51118);
April 13, 2004 (69 FR 19644); November
25, 2008 (73 FR 71858); December 10,
2008 (73 FR 75122); and on April 30,
2010 (75 FR 22809).
A notice listing all currently HHScertified laboratories and IITFs is
published in the Federal Register
during the first week of each month. If
any laboratory or IITF certification is
suspended or revoked, the laboratory or
IITF will be omitted from subsequent
lists until such time as it is restored to
SUMMARY:
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Page 19214]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07502]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Amended Notice of
Meeting
Notice is hereby given to clarify the meeting times of the Sleep
Disorders Research Advisory Board, April 14-15, 2016, NHLBI/National
Institutes of Health, Two Rockledge Center, 6701 Rockledge Drive,
Conference Room 9100/9104, Bethesda, MD, which was published in the
Federal Register on March 14, 2016, 81 FR 13399.
Time: April 14 1:00 p.m. to 5:00 p.m., April 15 8:30 a.m. to 3:00
p.m.
Agenda: Information will be presented on the status of selected NIH
sleep research programs and inter-agency coordination activities. The
Sleep Disorders Research Advisory Board will discuss a potential
framework for a revision of the NIH Sleep Disorders Research Plan. The
Board will also hear brief presentations from organizations and
individuals interested in NIH sleep research programs and planning.
Dated: March 29, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-07502 Filed 4-1-16; 8:45 am]
BILLING CODE 4140-01-P